Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Recommended Offer for Protec

18 Nov 2005 16:26

Quadnetics Group PLC18 November 2005 Quadnetics Group PLC18 November 2005 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THEUNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF IRELAND, SOUTH AFRICA OR JAPAN RECOMMENDED OFFER FOR PROTEC PLC Offer Extended As at 1.00 pm on 18 November 2005, valid acceptances had been received inrespect of 120,807,939 Protec Shares (representing approximately 75.26 per cent. of Protec's issued share capital). Prior to the posting of the Offer Document, Quadnetics had received irrevocable undertakings from the Protec Directors and certain other Protec Shareholders to accept the Offer in respect of, in aggregate, 99,758,979 Protec Shares representing 62.15 per cent. of the existing issued Protec Shares. Of these irrevocable undertakings the Board has received valid acceptances from, in aggregate, 78,252,406 Protec Shares, representing 48.75 per cent. of the existing issued Protec Shares. Quadnetics announces that it is extending the Offer until further notice. Now that Quadnetics has acceptances in relation to over 75 per cent. of Protec Shares, the process of de-listing Protec from AIM will commence. At a board meeting today 83,828 New Quadnetics Shares were allotted to holders of Protec Shares who had validly accepted the Offer. Settlement of consideration Application will be made to the London Stock Exchange for these New Quadnetics Shares to be admitted to trading on AIM on Thursday 24 November 2005. Delivery of share certificates/CREST transfers Share certificates for these New Quadnetics Shares will be despatched to Protec Shareholders who have validly accepted the Offer in respect of Protec Shares held in certificated form within 14 days. Transfer into CREST for Protec Shareholders who have accepted the Offer inrespect of these Protec Shares held in within CREST will take place with 14days. Terms defined in the Offer Document dated 30 September 2005 shall, unless thecontext requires otherwise, have the same meanings in this announcement. Enquiries Quadnetics 01527 850080Russ Singleton, Chief ExecutiveNigel Poultney, Finance Director Brewin Dolphin Securities Ltd 0113 241 0130(Financial Adviser and Corporate Broker to Quadnetics)Neil BaldwinKeith Williams Protec 01923 211550Bill Moir, Chief Executive Teather & Greenwood 020 7246 9000(Financial Adviser and Corporate Broker to Protec)Jeff KeatingRob Naylor Media Enquiries Abchurch Communications 0207 398 7700Chris MundenKathryn Murphy This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Apr 20217:00 amRNSSynectics secures major City of London project
31st Mar 20217:00 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSPosting of Accounts and Notice of AGM
17th Mar 20217:00 amRNSDirector’s/PCA’s Interest in Shares
4th Mar 20217:00 amRNSPDMR’s Interest in Shares
2nd Mar 20217:00 amRNSFinal Results
17th Feb 20217:00 amRNSFurther contract wins in Irish bus market
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.